Skip to main content

Colgate-Palmolive Company (CL-N) Quote - Press Release

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

More stories below advertisement

Look for Shares of Colgate-Palmoliv to Potentially Rebound after Yesterday's 2.19% Sell Off

Comtex SmarTrend(R) - Fri Sep 13, 10:05PM CDT

Colgate-Palmoliv (NYSE:CL) traded in a range yesterday that spanned from a low of $70.68 to a high of $71.17. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $71.18 on volume of 2.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend is monitoring the recent change of momentum in Colgate-Palmoliv. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Colgate-Palmoliv in search of a potential trend change.

Colgate-Palmoliv share prices have moved between a 52-week high of $76.41 and a 52-week low of $57.41 and are now trading 23% above that low price at $70.79 per share. The 200-day and 50-day moving averages have moved 0.35% higher and 0.14% higher over the past week, respectively.

Write to SmarTrend at cs@mysmartrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).